$TNXP Roth Capital Reiterates Buy On Tonix Pharmaceuticals As Risk-Reward Is Favorable http://www.smarteranalyst.com/2014/11/14/roth-capital-reiterates-buy-on-tonix-pharmaceuticals-as-risk-reward-is-favorable/